Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Study
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
Study to Evaluate the Safety and the Immunogenicity of a Second Generation Structurally Designed mRNA Vaccine Candidate Against Pandemic Influenza H5 HA Strain in Healthy Adult Participants Aged 18 Years and Older
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Olfactory Cleft Obstruction and Electrophysiological Field Potentials Predict Olfactory Restoration by Dupilumab in CRSwNP Patients.
- Status
- RECRUITING
- Phase
- N/A
Description of Patients With Type 1 Diabetes Treated With Teplizumab
- Status
- COMPLETED
- Phase
- N/A
Phase 1/2 Study of Chlamydia Trachomatis mRNA Vaccine in Adults Aged 18 to 29 Years
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
- Status
- RECRUITING
- Phase
- PHASE2
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE3
A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age.
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)
- Status
- RECRUITING
- Phase
- N/A
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
- Status
- RECRUITING
- Phase
- PHASE3
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
ELISA in Relapsed/Refractory MM
- Status
- RECRUITING
- Phase
- PHASE2
Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Actual Use Trial of Tadalafil 5 mg
- Status
- RECRUITING
- Phase
- PHASE3
Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 Diabetes
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
Societal Burden Associated With Type 1 Diabetes in Canada
- Status
- RECRUITING
- Phase
- N/A